A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology

スポンサーリンク

概要

• 論文の詳細を見る
• 2013-03-01

著者

• Miyasaka Nobuyuki

  Department Of Bioregulatory Medicine And Rheumatology Faculty Of Medicine Tokyo Medical And Dental U

• Harigai Masayoshi

  Department Of Medicine And Rheumatology Graduate School Tokyo Medical And Dental University

• Kameda Hideto

  Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Faculty Of Medicine

• Dohi Makoto

  Department Of Allergy And Rheumatology Graduate School Of Medicine The University Of Tokyo

• Nagasawa Hayato

  Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University

• Atsumi Tatsuya

  Department Of Internal Medicine Ii Hokkaido University Graduate School Of Medicine

• Seto Yohei

  Institute Of Rheumatology Tokyo Women's Medical University

• Hirata Shintaro

  The First Department Of Internal Medicine School Of Medicine University Of Occupational And Environmental Health

• KOIKE Takao

  Sapporo Medical Center NTT EC

• Miyasaka Nobuyuki

  Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

• Nagasawa Hayato

  Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University

• TAKAMURA Akito

  Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

関連論文

• Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
• Severe airflow limitation in two patients with systemic lupus erythematosus : effect of inhalation of anticholinergics
• Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
• Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis
• Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers
• Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis
• A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin)
• A case of paraneoplastic syndrome mimicking adult-onset Still's disease
• Development of TCRB CDR3 length repertoire of human T lymphocytes
• Two cases of acute respiratory distress syndrome resulting from adult-onset Still's disease
• Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p2l^ gene into the joints
• Treatment of Arthritis with Cyclin-dependent Kinase Inihibitor Gene
• Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis
• Pulmonary Exercise Testing Predicts Prognosis in Patients with Chronic Obstructive Pulmonary Disease
• Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis : results from the RISING study
• Cognitive dysfunction in systemic lupus erythematosus
• Inflammatory Cytokines as a Molecular Target in the Treatment of Inflammatory Disorders of Unknown Etiology
• Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis
• Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy
• Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation : the CHANGE study
• Revised Japanese criteria for Sjogren's syndrome (1999) : availability and validity
• Augmented Expression of CD44 Splice Variants in Lymphoproliferative Disorder of the Lacrimal Gland in Sjogren's Syndrome
• Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
• Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis : autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage
• Varicella-zoster virus hepatitis in polymyositis
• Polymyalgia rheumatica as the manifestation of unclassified aortitis
• The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β_2Glycoprotein I antibodies
• A Woman with Infectious Endocarditis Caused by Abiotrophia defectiva
• Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)
• Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
• Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
• Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis
• Improvement of the HAQ score by infliximab treatment in patients with RA : its association with disease activity and joint destruction
• Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab
• Impact of TNF inhibitors on rheumatoid arthritis
• Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis
• Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases
• Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis : a better response in male patients
• The inhibition of protein C anticoagulant activity by anti-β_2-glycoprotein I (β_2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods
• Antigenic structures recognized by anti-β2-glycoprotein I auto-antibodies
• Anti-β_2-glycoprotein I antibodies in children with atopic dermatitis
• Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
• Guidelines for the proper use of etanercept in Japan
• Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases
• Multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus
• Pneumatosis Cystoides Intestinalis Following Lupus Enteritis and Peritonitis
• Efficacy and safety of tacrolimus for lupus nephritis : a placebo-controlled double-blind multicenter study
• The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis
• Clinical and Radiological Features of Pneumocystis Pneumonia in Patients with Rheumatoid Arthritis, in comparison with Methotrexate Pneumonitis and Pneumocystis Pneumonia in Acquired Immunodeficiency Syndrome: A Multicenter Study
• Long-term vasodilator therapy of pulmonary hypertension in mixed connective tissue disease
• Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome
• Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis
• Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy : a randomized trial
• Regulatory T cells in the control of T cell homeostasis
• Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan : results from a retrospective study (REACTION study)
• The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
• A case of IgG4-related disease with features of Mikulicz's disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman's disease
• Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematousus
• Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
• Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006
• Studies of the efficacy and safety of methotrexate at dosages over 8mg/week using the IORRA cohort database
• A case of Behcet's disease with widespread perforating enteric ulcers preceded by a long history of peripheral gangrene
• Comparison of characteristics and therapeutic efficacy in rheumatoid arthritis patients treated by rheumatologists and those treated by orthopedic surgeons under a team medicine approach at the same institute
• Recurrence of Chronic Active Epstein-Barr Virus Infection from Donor Cells after Achieving Complete Response Through Allogeneic Bone Marrow Transplantation
• Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept
• Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis : the JMAAV study
• Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids : a randomized double-blind placebo-controlled trial
• Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis : retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
• A Case of Multiple Giant Coronary Aneurysms and Abdominal Aortic Aneurysm Coexisting with IgG4-related Disease
• Addition of the collagen binding domain of fibronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing
• Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients : postmarketing surveillance report of the first 3,000 patients
• A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β_2 glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies
• Successful Treatment of Class IV+V Lupus Nephritis with Combination Therapy of High-dose Corticosteroids, Tacrolimus and Intravenous Cyclophosphamide
• Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis : a retrospective review of 15 cases and analysis of risk factors
• Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity
• Overlap Syndrome with Cerebral Hemorrhage caused by Prostaglandin E1 Infusion.
• Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjogren's syndrome
• Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome
• Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis : a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs
• A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology
• Management of rheumatoid arthritis : the 2012 perspective
• Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
• Tolerability and effecacy of abatacept in Japanese patients with rheumatoid arthritis : a phase I study
• Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA

もっと見る 閉じる

スポンサーリンク